Annual FCF
-$98.88 M
+$68.14 M+40.80%
December 1, 2024
Summary
- As of March 12, 2025, ADPT annual free cash flow is -$98.88 million, with the most recent change of +$68.14 million (+40.80%) on December 1, 2024.
- During the last 3 years, ADPT annual FCF has risen by +$155.60 million (+61.14%).
- ADPT annual FCF is now -150.91% below its all-time high of $194.20 million, reached on December 31, 2019.
Performance
ADPT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$12.57 M
+$14.84 M+54.14%
December 1, 2024
Summary
- As of March 12, 2025, ADPT quarterly free cash flow is -$12.57 million, with the most recent change of +$14.84 million (+54.14%) on December 1, 2024.
- Over the past year, ADPT quarterly FCF has increased by +$14.84 million (+54.14%).
- ADPT quarterly FCF is now -104.58% below its all-time high of $274.47 million, reached on March 31, 2019.
Performance
ADPT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$98.88 M
+$15.66 M+13.67%
December 1, 2024
Summary
- As of March 12, 2025, ADPT TTM free cash flow is -$98.88 million, with the most recent change of +$15.66 million (+13.67%) on December 1, 2024.
- Over the past year, ADPT TTM FCF has increased by +$15.66 million (+13.67%).
- ADPT TTM FCF is now -140.76% below its all-time high of $242.60 million, reached on March 31, 2019.
Performance
ADPT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ADPT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.8% | +54.1% | +13.7% |
| 3 y3 years | +61.1% | +76.0% | +59.0% |
| 5 y5 years | -150.9% | +76.0% | +59.0% |
ADPT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.1% | at high | +81.4% | at high | +61.1% |
| 5 y | 5-year | -150.9% | +61.1% | at high | +83.0% | -150.9% | +61.1% |
| alltime | all time | -150.9% | +61.1% | -104.6% | +83.0% | -140.8% | +61.1% |
Adaptive Biotechnologies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$98.88 M(-40.8%) | -$12.57 M(-54.1%) | -$98.88 M(-13.7%) |
| Sep 2024 | - | -$27.41 M(+44.0%) | -$114.53 M(-16.1%) |
| Jun 2024 | - | -$19.03 M(-52.3%) | -$136.59 M(-5.7%) |
| Mar 2024 | - | -$39.86 M(+41.2%) | -$144.81 M(-13.3%) |
| Dec 2023 | -$167.02 M(-16.6%) | -$28.23 M(-42.9%) | -$167.02 M(-2.5%) |
| Sep 2023 | - | -$49.46 M(+81.5%) | -$171.35 M(+1.0%) |
| Jun 2023 | - | -$27.25 M(-56.1%) | -$169.73 M(-12.9%) |
| Mar 2023 | - | -$62.08 M(+90.6%) | -$194.84 M(-2.7%) |
| Dec 2022 | -$200.29 M(-21.3%) | -$32.56 M(-31.9%) | -$200.29 M(-13.2%) |
| Sep 2022 | - | -$47.84 M(-8.6%) | -$230.80 M(-4.2%) |
| Jun 2022 | - | -$52.36 M(-22.5%) | -$241.03 M(-2.8%) |
| Mar 2022 | - | -$67.53 M(+7.1%) | -$247.92 M(-2.6%) |
| Dec 2021 | -$254.47 M | -$63.07 M(+8.6%) | -$254.47 M(+5.8%) |
| Sep 2021 | - | -$58.06 M(-2.0%) | -$240.62 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$59.25 M(-20.0%) | -$233.92 M(+12.5%) |
| Mar 2021 | - | -$74.09 M(+50.5%) | -$208.00 M(+23.5%) |
| Dec 2020 | -$168.49 M(-186.8%) | -$49.21 M(-4.2%) | -$168.49 M(+13.5%) |
| Sep 2020 | - | -$51.36 M(+54.1%) | -$148.48 M(+13.6%) |
| Jun 2020 | - | -$33.34 M(-3.6%) | -$130.68 M(+13.8%) |
| Mar 2020 | - | -$34.57 M(+18.4%) | -$114.84 M(-159.1%) |
| Dec 2019 | $194.20 M(-603.7%) | -$29.21 M(-13.0%) | $194.20 M(-9.9%) |
| Sep 2019 | - | -$33.57 M(+91.9%) | $215.51 M(-8.4%) |
| Jun 2019 | - | -$17.49 M(-106.4%) | $235.20 M(-3.1%) |
| Mar 2019 | - | $274.47 M(-3572.1%) | $242.60 M(-729.2%) |
| Dec 2018 | -$38.56 M(+3.2%) | -$7.91 M(-43.0%) | -$38.56 M(+25.8%) |
| Sep 2018 | - | -$13.88 M(+37.6%) | -$30.65 M(+82.7%) |
| Jun 2018 | - | -$10.09 M(+50.7%) | -$16.78 M(+150.7%) |
| Mar 2018 | - | -$6.69 M | -$6.69 M |
| Dec 2017 | -$37.36 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual free cash flow?
- What is the all time high annual FCF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual FCF year-on-year change?
- What is Adaptive Biotechnologies quarterly free cash flow?
- What is the all time high quarterly FCF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly FCF year-on-year change?
- What is Adaptive Biotechnologies TTM free cash flow?
- What is the all time high TTM FCF for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM FCF year-on-year change?
What is Adaptive Biotechnologies annual free cash flow?
The current annual FCF of ADPT is -$98.88 M
What is the all time high annual FCF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual free cash flow is $194.20 M
What is Adaptive Biotechnologies annual FCF year-on-year change?
Over the past year, ADPT annual free cash flow has changed by +$68.14 M (+40.80%)
What is Adaptive Biotechnologies quarterly free cash flow?
The current quarterly FCF of ADPT is -$12.57 M
What is the all time high quarterly FCF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly free cash flow is $274.47 M
What is Adaptive Biotechnologies quarterly FCF year-on-year change?
Over the past year, ADPT quarterly free cash flow has changed by +$14.84 M (+54.14%)
What is Adaptive Biotechnologies TTM free cash flow?
The current TTM FCF of ADPT is -$98.88 M
What is the all time high TTM FCF for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM free cash flow is $242.60 M
What is Adaptive Biotechnologies TTM FCF year-on-year change?
Over the past year, ADPT TTM free cash flow has changed by +$15.66 M (+13.67%)